Sign in

Radiation safety, contrast and gadolinium in pain procedures

Procedural · G4a · Reviewed by a board-certified pain physician on October 31, 2026

Bottom line

Distance, time and shielding limit radiation. Contrast matters most where an intravascular injection could injure the cord or brain: without it, postpone high-level transforaminal, upper cervical and sympathetic procedures, and never give gadolinium where subarachnoid spread is possible.

Key points

  1. Distance is the strongest radiation tool. Exposure follows the inverse square law, so doubling the distance from the scatter source cuts exposure to about one-quarter; scatter at 1 m is roughly 0.1% of the patient's absorbed dose rate 12.
  2. Rank procedures by contrast dependence. The 2022 multisociety advisory says transforaminal injections and selective nerve blocks at L2 and above, atlanto-axial and atlanto-occipital injections, and stellate blocks should be postponed if iodinated contrast is unavailable 3.
  3. Lower-risk procedures may proceed. Lumbar interlaminar epidurals and medial branch blocks are lowest importance; transforaminal injections below L2 may proceed without contrast only with a nonparticulate steroid such as dexamethasone 3.
  4. Interlaminar epidural without contrast: adjust the injectate. Consider omitting local anesthetic, because a dural breach could cause a high spinal, and use preservative-free steroid in case of intrathecal injection 3.
  5. Use ultrasound where it is proven. Some procedures, such as stellate ganglion block under ultrasound by experienced operators, can be done without iodinated contrast 3.
  6. Gadolinium is not a neuraxial substitute. Gadolinium-based contrast may be an alternative for some procedures but should be avoided in any neuraxial procedure with risk of subarachnoid injection, such as epidural steroid injections 3.

Watch for

Intrathecal gadolinium can be catastrophic; never substitute it for iodinated contrast in epidural or other neuraxial injections 3.

High-yield for the exam

  • Moving from 0.5 m to 1 m from the scatter source reduces exposure to one-quarter 1.
  • Assistants standing farther from the source receive less exposure than operators 2.
  • Transforaminal injections at L2 and above carry radiculomedullary artery risk and need contrast 3.
  • Do not draw from one contrast vial for multiple patients; only pharmacists may repackage vials, under sterile conditions 3.
  • Discuss the risks of proceeding without contrast with the patient beforehand and document it 3.
  • Cord injury after transforaminal injection is not confined to L2 and above; cases are documented from L3 to S1 3.
  • Options during a shortage include postponing, proceeding without contrast, using gadolinium where safe, ultrasound techniques, or an alternative treatment 3.
  • Staff should keep doses as low as reasonably achievable (ALARA) while still obtaining adequate images 1.

Numbers to know

Item Value
Exposure at double the distance about 1/4 1
Scatter at 1 m from the patient about 0.1% of patient dose rate 2
Transforaminal level requiring contrast L2 and above 3
Repackaged iohexol BUD at room temperature 30 hours 3
Repackaged iohexol BUD refrigerated 9 days 3

Common traps

  • Using a particulate steroid for a transforaminal injection done without contrast 3.
  • Substituting gadolinium for an epidural steroid injection 3.
  • Doing a stellate block without contrast and without ultrasound expertise 3.
  • Assuming the operator and assistant receive the same dose regardless of where they stand 2.

Practise this topic

5 more questions on this topic in the full question bank, with explanations and sources.

Sources

  1. Ahmed M, Ahmed R. Radiation in gastroenterology. Gastroenterology Res, 2022. pmc.ncbi.nlm.nih.gov/articles/PMC9822665/
  2. Kim TW, et al. Radiation exposure to physicians during interventional pain procedures. Korean J Pain, 2010. pmc.ncbi.nlm.nih.gov/articles/PMC2884203/
  3. Schuster NM, et al. Best practices for interventional pain procedures in the setting of an iodinated contrast media shortage: a multisociety practice advisory. Interv Pain Med, 2022. pmc.ncbi.nlm.nih.gov/articles/PMC11372943/

Related topics

Independent study material for the ABA Pain Medicine exam, written and reviewed by a board-certified pain physician. Not medical advice; not affiliated with the American Board of Anesthesiology.